In drug delivery, the therapeutic behavior of the nanocarriers is limited by the “foreign” character of their surface. Despite the wide range of sophisticated coatings available, immune cells often identify these synthetic nanoparticles, generating adverse responses or showing strong off-target accumulation.
Click here for original story, Cell-derived nanocarriers for more efficient and direct intracellular drug release
Source: Phys.org